143 related articles for article (PubMed ID: 37666022)
1. Impact of pathological nodal staging and tumour differentiation on survival and postoperative radiotherapy in completely resected stage IIIA Non-small-cell lung cancer.
Ku HY; Lin SM; Wang CL; Lo YC; Chang CS; Chang GC; Ch'ang HJ; Liu TW
Lung Cancer; 2023 Oct; 184():107357. PubMed ID: 37666022
[TBL] [Abstract][Full Text] [Related]
2. The high-risk features and effect of postoperative radiotherapy on survival for patients with surgically treated stage IIIA-N2 non-small cell lung cancer.
Zhu M; Li S; Yuan L; Liu S; Li J; Zhang D; Chen J; Jiang J; Xu Z
World J Surg Oncol; 2023 Aug; 21(1):238. PubMed ID: 37537652
[TBL] [Abstract][Full Text] [Related]
3. Postoperative radiotherapy with modern techniques does not improve survival for operable stage IIIA-N2 non-small cell lung cancer.
Predina J; Suliman R; Potter AL; Panda N; Diao K; Lanuti M; Muniappan A; Jeffrey Yang CF
J Thorac Cardiovasc Surg; 2023 May; 165(5):1696-1709.e4. PubMed ID: 36610886
[TBL] [Abstract][Full Text] [Related]
4. Choice of postoperative radiation for stage IIIA pathologic N2 non-small cell lung cancer: impact of metastatic lymph node number.
Wang S; Ma Z; Yang X; Wang Y; Xu Y; Xia W; Chen R; Qiu M; Jiang F; Yin R; Xu L; Xu K
Radiat Oncol; 2017 Dec; 12(1):207. PubMed ID: 29284511
[TBL] [Abstract][Full Text] [Related]
5. Postoperative radiotherapy for resected pathological stage IIIA-N2 non-small cell lung cancer: a retrospective study of 221 cases from a single institution.
Dai H; Hui Z; Ji W; Liang J; Lu J; Ou G; Zhou Z; Feng Q; Xiao Z; Chen D; Zhang H; Yin W; He J; Wang L
Oncologist; 2011; 16(5):641-50. PubMed ID: 21482587
[TBL] [Abstract][Full Text] [Related]
6. Postoperative radiotherapy for pathological stage IIIA-N2 non-small cell lung cancer with positive surgical margins.
Yuan M; Men Y; Kang J; Sun X; Zhao M; Bao Y; Yang X; Sun S; Ma Z; Wang J; Deng L; Wang W; Zhai Y; Liu W; Zhang T; Wang X; Bi N; Lv J; Liang J; Feng Q; Chen D; Xiao Z; Zhou Z; Wang L; Hui Z
Thorac Cancer; 2021 Jan; 12(2):227-234. PubMed ID: 33247556
[TBL] [Abstract][Full Text] [Related]
7. Role of Postoperative Radiotherapy in Pathologic Stage IIIA (N2) Non-Small Cell Lung Cancer in a Prospective Nationwide Oncology Outcomes Database.
Herskovic A; Mauer E; Christos P; Nagar H
J Thorac Oncol; 2017 Feb; 12(2):302-313. PubMed ID: 27746190
[TBL] [Abstract][Full Text] [Related]
8. Log odds of positive lymph nodes is a robust predictor of survival and benefits from postoperative radiotherapy in stage IIIA-N2 resected non-small cell lung cancer.
Jin X; Chen D; Shen Y; Shu J; Sang Y; Yang W; Duan S; Chen Y
Thorac Cancer; 2022 Oct; 13(19):2767-2775. PubMed ID: 36054738
[TBL] [Abstract][Full Text] [Related]
9. Postoperative radiotherapy for patients with completely resected pathological stage IIIA-N2 non-small cell lung cancer: a preferential benefit for squamous cell carcinoma.
Tian C; Liu G; Xu Y; Xia G; Zhang T; Huang J; Jiang H; Ming Wang J; Li B
Radiol Oncol; 2020 Dec; 55(1):66-76. PubMed ID: 33885242
[TBL] [Abstract][Full Text] [Related]
10. Role of postoperative radiotherapy after curative resection and adjuvant chemotherapy for patients with pathological stage N2 non-small-cell lung cancer: a propensity score matching analysis.
Kim BH; Kim HJ; Wu HG; Kang CH; Kim YT; Lee SH; Kim DW
Clin Lung Cancer; 2014 Sep; 15(5):356-64. PubMed ID: 24996882
[TBL] [Abstract][Full Text] [Related]
11. The emerging outcome of postoperative radiotherapy for stage IIIA(N2) non-small cell lung cancer patients: based on the three-dimensional conformal radiotherapy technique and institutional standard clinical target volume.
Feng W; Zhang Q; Fu XL; Cai XW; Zhu ZF; Yang HJ; Xiang JQ; Zhang YW; Chen HQ
BMC Cancer; 2015 May; 15():348. PubMed ID: 25934006
[TBL] [Abstract][Full Text] [Related]
12. Effects of Postoperative Radiotherapy on Survival of Patients With Stage IIIA Resected Non-Small Cell Lung Cancer: Analysis of the SEER Database.
Gao F; Li N; Xu Y; Yang G
J Natl Compr Canc Netw; 2020 Jun; 18(6):718-727. PubMed ID: 32502986
[TBL] [Abstract][Full Text] [Related]
13. Effect of Postoperative Radiotherapy for Patients With pIIIA-N2 Non-Small Cell Lung Cancer After Complete Resection and Adjuvant Chemotherapy: The Phase 3 PORT-C Randomized Clinical Trial.
Hui Z; Men Y; Hu C; Kang J; Sun X; Bi N; Zhou Z; Liang J; Lv J; Feng Q; Xiao Z; Chen D; Wang Y; Li J; Wang J; Gao S; Wang L; He J
JAMA Oncol; 2021 Aug; 7(8):1178-1185. PubMed ID: 34165501
[TBL] [Abstract][Full Text] [Related]
14. Impact of postoperative radiation therapy on survival in patients with complete resection and stage I, II, or IIIA non-small-cell lung cancer treated with adjuvant chemotherapy: the adjuvant Navelbine International Trialist Association (ANITA) Randomized Trial.
Douillard JY; Rosell R; De Lena M; Riggi M; Hurteloup P; Mahe MA;
Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):695-701. PubMed ID: 18439766
[TBL] [Abstract][Full Text] [Related]
15. The Prognostic Role of PORT and EGFR Mutation Status in Completely Resected Stage IIIA/N2 Non-Small Cell Lung Cancer Patients with Postoperative Chemotherapy.
Yang H; Wang K; Li S; Li Y; Yuan L
Pathol Oncol Res; 2021; 27():1609898. PubMed ID: 34447289
[No Abstract] [Full Text] [Related]
16. Propensity score-matching analysis of postoperative radiotherapy for stage IIIA-N2 non-small cell lung cancer using the Surveillance, Epidemiology, and End Results database.
Wei S; Xie M; Tian J; Song X; Wu B; Liu L
Radiat Oncol; 2017 Jun; 12(1):96. PubMed ID: 28610591
[TBL] [Abstract][Full Text] [Related]
17. Adjuvant radiotherapy and chemotherapy for stage II or IIIA non-small-cell lung cancer after complete resection. Provincial Lung Cancer Disease Site Group.
Logan DM; Lochrin CA; Darling G; Eady A; Newman TE; Evans WK
Cancer Prev Control; 1997 Dec; 1(5):366-78. PubMed ID: 9765759
[TBL] [Abstract][Full Text] [Related]
18. Patient prognostic scores and association with survival improvement offered by postoperative radiotherapy for resected IIIA/N2 non-small cell lung cancer: A population-based study.
Xu L; Xie HN; Chen XK; Bi N; Qin JJ; Li Y
Thorac Cancer; 2021 Mar; 12(6):760-767. PubMed ID: 33481353
[TBL] [Abstract][Full Text] [Related]
19. Postoperative Radiotherapy for Resected Stage IIIA-N2 Non-small-cell Lung Cancer: A Population-Based Time-Trend Study.
Zeng WQ; Feng W; Xie L; Zhang CC; Yu W; Cai XW; Fu XL
Lung; 2019 Dec; 197(6):741-751. PubMed ID: 31705271
[TBL] [Abstract][Full Text] [Related]
20. Postoperative Radiation Therapy Is Associated With Improved Overall Survival in Incompletely Resected Stage II and III Non-Small-Cell Lung Cancer.
Wang EH; Corso CD; Rutter CE; Park HS; Chen AB; Kim AW; Wilson LD; Decker RH; Yu JB
J Clin Oncol; 2015 Sep; 33(25):2727-34. PubMed ID: 26101240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]